Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy

Transplantation and Cellular Therapy(2023)

引用 3|浏览10
暂无评分
关键词
cytokine release syndrome,siltuximab,neurotoxicity,investigator-initiated,t-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要